Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity

The coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2, has recently emerged worldwide. In this context, there is an urgent need to identify safe and effective therapeutic strategies for treatment of such highly contagious disease. We recent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Microb Drug Resist
Autors principals: Hache, Guillaume, Rolain, Jean Marc, Gautret, Philippe, Deharo, Jean-Claude, Brouqui, Philippe, Raoult, Didier, Honoré, Stéphane
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc., publishers 2021
Matèries:
Opinion Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7987362/
https://ncbi.nlm.nih.gov/pubmed/33729874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/mdr.2020.0232
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars